Primary congenital glaucoma: 2004 Update

Journal of Pediatric Ophthalmology and Strabismus

Volumn 41, Issue 5, 2004, Pages 271-288

  Ching, Lin Ho ^a   Walton, David S ^b,c  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CYTOCHROME P450 1B1; DORZOLAMIDE; LATANOPROST; METHAZOLAMIDE; MIOTIC AGENT; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TRAVOPROST;

APNEA; AUTOSOMAL RECESSIVE INHERITANCE; BLINDNESS; BONE MARROW SUPPRESSION; BRADYCARDIA; BRONCHOSPASM; CLINICAL EXAMINATION; CLINICAL FEATURE; CONGENITAL GLAUCOMA; CONJUNCTIVAL HYPEREMIA; CORNEA EDEMA; CORNEA OPACITY; CYCLODESTRUCTION; DIFFERENTIAL DIAGNOSIS; EPIPHORA; EYE SURGERY; FAMILIAL DISEASE; FATIGUE; GENE IDENTIFICATION; GENE LOCUS; GENERAL ANESTHESIA; GLAUCOMA DRAINAGE IMPLANT; GONIOTOMY; HISTOPATHOLOGY; HUMAN; HYPERPNEA; HYPOTENSION; HYPOTHERMIA; IMPLANTATION; INTRAOCULAR PRESSURE; IRIS DISEASE; METABOLIC ACIDOSIS; MUSCLE HYPOTONIA; NEPHROLITHIASIS; NEUROTOXICITY; PEDIATRIC SURGERY; PRIMARY GLAUCOMA; REVIEW; SECONDARY GLAUCOMA; SIDE EFFECT; SKIN PIGMENTATION; SOMNOLENCE; SURGICAL TECHNIQUE; TRABECULAR MESHWORK; TRABECULECTOMY; TRABECULOTOMY; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

EID: 4644299672     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: 10.3928/01913913-20040901-11     Document Type: Review

References (106)

1. Hoskins HD Jr, Shaffer RN, Hetherington J. Anatomical classification of the developmental glaucomas. Arch Ophthalmol 1984;102:1331-1336.
2. Miller SJH. Genetic aspects of glaucoma. Transactions Ophthalmological Society of the United Kingdom 1966;86:425-434.
3. Debnath SC, Teichmann KD, Salamah K. Trabeculectomy versus trabeculotomy in congenital glaucoma. Br J Ophthalmol 1989;73:608-611.
4. Gencik A. Epidemiology and genetics of primary congenital glaucoma in Slovakia: description of a form of primary congenital glaucoma in gypsies with autosomal-recessive inheritance and complete penetrance. Dev Ophthalmol 1989;16:76-115.
5. Taylor RH, Ainsworth JR, Evans AR, Levin AV. The epidemiology of pediatric glaucoma: the Toronto experience. J AAPOS 1999;3:308-315.
6. Gao DW, Kubota T, Sugino K, Sugai S, Inomata H. A statistical comparison study of glaucoma in the Third Affiliated Hospital of China Medical College and Kyushi University [in Japanese]. Nippon Ganka Gakkai Zasshi 1989;93:458-465.
7. DeLuise VP, Anderson DR. Primary infantile glaucoma (congenital glaucoma). Surv Ophthalmol 1983;28:1-19.
8. Shaffer RN. Genetics and the congenital glaucomas. Am J Ophthalmol 1965;60:981-994.
9. Kolker AE, Hetherington J. Congenital glaucoma. In: Becker-Shaffer's Diagnosis and Therapy of the Glaucomas, ed. 5. St. Louis: CV Mosby; 1983:317-369.
10. Sarfarazi M, Stoilov I. Molecular genetics of primary congenital glaucoma. Eye 2000;14:422-428.
11. Gencik A, Gencikova A, Gerinec A. Genetic heterogeneity of congenital glaucoma. Clin Genet 1980;17:241-248.
12. Akarsu AN, Turacli ME, Aktan SG, et al. A second locus (GLC3B) for primary glaucoma (buphthalmos) maps to the 1p36 region. Hum Mol Genet 1996;5:1199-1203.
13. Stoilov IR, Sarfarazi M. The third genetic locus (GLC3C) for primary congenital glaucoma (PCG) maps to chromosome 14q24.3. Presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology; May 1-5, 2002; Fort Lauderdale, FL.
14. Sarfarazi M, Arkarsu AN, Hossain A, et al. Assignment of a locus (GLC3A) for primary congenital glaucoma (buphthalmos) to 2p21 and evidence for genetic heterogeneity. Genomics 1995;30:171-178.
15. Stoilov I, Nurten A, Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma in families linked to the GLC3A on chromosome 2p21. Hum Mol Genet 1997;6:641-647.
16. Bejjani BA, Lewis RA, Tomey KF, et al. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 1998;62:325-333.
17. Bejjani BA, Stockton DW, Lewis RA, et al. Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus. Hum Mol Genet 2000;9:367-374.
18. Panicker SG, Mandal AN, Reddy ABM, Gothwal VK, Hasnain SE. Correlations of genotype with phenotype in Indian patients with primary congenital glaucoma. Invest Ophthalmol Vis Sci 2004;45:1149-1156.
19. Sarfarazi M, Stoilov I, Schenkman JB. Genetics and biochemistry of congenital glaucoma. Ophthalmol Clin North Am 2003;16:543-554.
20. Alward WL, Semina EV, Kalenak JW, et al. Autosomal dominant iris hypoplasia is caused by a mutation in the Rieger syndrome (RIEG/PITX2) gene. Am J Ophthalmol 1998;125:98-100.
21. Nishimura DY, Swiderski RE, Alward WLM, et al. The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet 1998;19:140-147.
22. Alward WL, Fingert JH, Coote MA, et al. Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A). N Engl J Med 1998;338:1022-1023.
23. Vincent AL, Billingsley G, Buys Y, et al. Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet 2002;70:448-460.
24. Anderson DR. Pathology of the glaucomas. Br J Ophthalmol 1972;56:146-157.
25. Tawara A, Inomata H. Developmental immaturity of the trabecular meshwork in congenital glaucoma. Am J Ophthalmol 1981;92:508-525.
26. Barkan O. Pathogenesis of congenital glaucoma: gonioscopic and anatomic observation of the angle of the anterior chamber in the normal eye and in congenital glaucoma. Am J Ophthalmol 1955;40:1-11.
27. Worst JGF. Congenital glaucoma: remarks on the aspect of chamber angle, ontogenetic and pathogenetic background, and mode of action of goniotomy. Invest Ophthalmol 1968;7:127-134.
28. Anderson DR. The development of the trabecular meshwork and its abnormality in primary infantile glaucoma. Trans Am Ophthalmol Soc 1981;79:458-485.
29. Tawara A, Inomata H, Tsukamoto S. Ciliary body band width as an indicator of goniodysgenesis. Am J Ophthalmol 1996;122:790-800.
30. Maul E, Strozzi L, Munoz C, Reyes C. The outflow pathway in congenital glaucoma. Am J Ophthalmol 1980;89:667-675.
31. Tawara A, Inomata H. Congenital abnormalities of the trabecular meshwork in primary glaucoma with open angle. Glaucoma 1987;9:28-34.
32. Tawara A, Inomata H. Developmental immaturity of the trabecular meshwork in congenital glaucoma. Am J Ophthalmol 1981;92:508-525.
33. Maumenee AE. The pathogenesis of congenital glaucoma: a new theory. Trans Am Ophthalmol Soc 1958;56:507-570.
34. Wright JD, Robb RM, Deuker DK, Boger WP. Congenital glaucoma unresponsive to conventional therapy: a clinicopathological case presentation. J Pediatr Ophthalmol Strabismus 1983;20:172-179.
35. Jaafar RN, Ghulamqadir AK. Effect of oral choral hydrate on the intraocular pressure measurement. J Pediatr Ophthalmol Strabismus 1993;30:372-376.
36. Watcha MF, Chu FC, Stevens JL, Forestner JE. Effects of halothane on intraocular pressure in anesthetized children. Anesth Analg 1990;71:181-184.
37. Marmor M, Beauchamp G, Maddox SF. Photophobia, epiphoria, torticollis: a masquerade syndrome. J Pediatr Ophthalmol Strabismus 1990;27:202-204.
38. Walton DS. Diagnosis and treatment of glaucoma in childhood. In: Epstein DL, ed. Chandler and Grant's Glaucoma. Philadelphia: Lea and Febinger; 1986.
39. Ho CL, Walton DS. Primary megalocornea: clinical features for differentiation from infantile glaucoma. J Pediatr Ophthalmol Strabismus 2004;41:11-17.
40. Freedman SF. Primary congenital glaucoma. In: Albert DM, Jacobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia: W. B. Saunders; 2000.
41. Rubenstein MA, Bucy JG. Acetazolamide-induced renal calculi. J Urol 1975;114:610-612.
42. Fraunfelder FT, Meyer SM, Bagby GC Jr, Dreis MW Hematologic reactions to carbonic anhydrase inhibitors. Am J Ophthalmol 1985;100:79-81.
43. Larsson LI, Alm A. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide. Arch Ophthalmol 1998;116:19-24.
44. Portellos M, Buckley EG, Freedman SF. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. J AAPOS 1998;2:43-47.
45. Wayman LL, Larsson LI, Maus TL, Brubaker RF. Additive effect of dorzolamide on aqueous humor flow in patients receiving long-term treatment with timolol. Arch Ophthalmol 1998;116:1438-1440.
46. Zimmerman TJ, Kooner KS, Morgan KS. Safety and efficacy of timolol in pediatric glaucoma. Sun Ophthalmol 1983;28(suppl):262-264.
47. Hoskins HD Jr, Hetherington J Jr, Magee SD, Naykhin R, Migliazzo CV. Clinical experience with timolol in childhood glaucoma. Arch Ophthalmol 1985;103:1163-1165.
48. McMahon CD, Hetherington J Jr, Hoskins HD Jr, Shaffer RN. Timolol and pediatric glaucomas. Ophthalmology 1981;88:249-252.
49. Williams T Ginther WH. Hazard of ophthalmic timolol. N Engl J Med 1982;306:1485-1486.
50. Olson RJ, Bromberg BB, Zimmerman TJ. Apneic spells associated with timolol therapy in a neonate. Am J Ophthalmol 1979;88:120-121.
51. Passo MS, Palmer EA, Van Buskirk EM. Plasma timolol in glaucoma patients. Ophthalmology 1984;91:1361-1363.
52. Toris CB, Gleason ML, Camras CB, Yablonski ME. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol 1995;113:1514-1517.
53. Juzych M, Robin A, Novack G. Alpha-2 agonists in glaucoma therapy. In: Zimmerman T, Kooner K, Sharir M, Fechtner R, eds. Textbook of Ocular Pharmacology. Philadelphia: Lippincott-Raven; 1997:247-254.
54. Carlsen JO, Zabriskie NA, Kwon YH, Barbe ME, Scott WE. Apparent central nervous system depression in infants after the use of topical brimonidine. Am J Ophthalmol 1999;128:255-256.
55. Korsch E, Grote A, Seybold M, Soditt V Systemic adverse effects of topical treatment with brimonidine in an infant with secondary glaucoma. Eur J Pediatr 1999;158:685.
56. Mungan NK, Wilson TW, Nischal KK, Koren G, Levin AV. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers. J AAPOS 2003;7:69-70.
57. Berlin RJ, Lee UT, Samples JR, et al. Ophthalmic drops causing coma in an infant. J Pediatr 2001;138:441-443.
58. Enyedi LB, Freedman SF. Safety and efficacy of brimonidine in children with glaucoma. J AAPOS 2001;5:281-284.
59. Parrish RK, Palmberg P, Sheu WP, XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003;135:688-703.
60. Enyedi LB, Freedman SF. Latanoprost for the treatment of pediatric glaucoma. Surv Ophthalmol 2002;47(suppl 1):S129-S132.
61. Enyedi LB, Freedman SF, Buckley EG. The effectiveness of latanoprost for the treatment of pediatric glaucoma. J AAPOS 1999;3:33-39.
62. Barkan O. Technique of goniotomy. Arch Ophthalmol 1938;19:217-223.
63. Barkan O. Operation for congenital glaucoma. Am J Ophthalmol 1942;25:552-568.
64. de Luise VP, Anderson DR. Primary infantile glaucoma (congenital glaucoma). Surv Ophthalmol 1983;28:1-19.
65. Haas J. Principles and problems of therapy in congenital glaucoma. Invest Ophthalmol 1968;7:140-146.
66. Boughton WI, Parks MM. An analysis of treatment of congenital glaucoma by goniotomy. Am J Ophthalmol 1981;91:566-572.
67. Mandal AK, Gothwal VK, Bagga H, Nutheti R, Mansoori T. Outcome of surgery on infants younger than 1 month with congenital glaucoma. Ophthalmology 2003;110:1909-1915.
68. Shaffer RN. Prognosis of goniotomy in primary infantile glaucoma (trabeculodysgenesis). Trans Am Ophthalmol Soc 1982;80:321-325.
69. Russell-Eggitt IM, Rice NSC, Barrie J, Wyse RKH. Relapse following goniotomy for congenital glaucoma due to trabecular dysgenesis. Eye 1992;6:197-200.
70. Richardson KL, Fetguson WJ, Schaffer RN. Long-term functional results in infantile glaucoma. Transactions of the American Academy of Ophthalmology and Otolaryngology 1967;71:833-836.
71. Walton DS. Goniotomy. In: Thomas JV, ed. Glaucoma Surgery. St. Louis: Mosby-Yearbook; 1992:107-121.
72. Joos KM, Shen JH. An ocular endoscope enables a goniotomy despite a cloudy cornea. Arch Ophthalmol 2001;119:134-135.
73. McPherson SD Jr. Results of external trabeculotomy. Trans Am Ophthalmol Soc 1973;71:163-170.
74. McPherson SD Jr, MacFarland D. External trabeculotomy for developmental glaucoma. Ophthalmology 1980;87:302-305.
75. McPherson SD Jr, Berry DP. Goniotomy vs external trabeculotomy for developmental glaucoma. Ophthalmology 1980;87:302-305.
76. Mandal A, Naduvilath TJ, Jayagandan DO. Surgical results of combined trabeculotomy-trabeculectomy for developmental glaucoma. Ophthalmology 1998;105:974-982.
77. Harms H, Dannheim R. Epicritical consideration of 300 cases of trabeculotomy ab externo. Transactions Ophthalmological Society of the United Kingdom 1969;89:491-499.
78. Shrader CE, Cibis GW. Trabeculotomy. In: Thomas JV, ed. Glaucoma Surgery. St. Louis: Mosby-Yearbook; 1992:123-131.
79. Mendicino ME, Lynch MG, Drack A, et al. Long-term surgical and visual outcomes in primary congenital glaucoma: 360 degrees trabeculotomy versus goniotomy. J AAPOS 2000;4:205-210.
80. Akimoto M, Tamihara H, Negi A, Nagata M. Surgical results of trabeculotomy ab externo for developmental glaucoma. Arch Ophthalmol 1994;112:1540-1544.
81. Filous A, Brunova B. Results of the modified trabeculotomy in the treatment of primary congenital glaucoma. J AAPOS 2002;6:182-186.
82. Beauchamp GR, Parks MM. Filtering surgery in children: barriers to success. Ophthalmology 1979;86:170-180.
83. Beck AD, Wilson WR, Lynch MG, Lynn MJ, Noe R. Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol 1998;126:648-657.
84. Freedman S, McCormick K, Cox T. Mitomycin C-augmented trabeculectomy with postoperative wound modulation in pediatric glaucoma. J AAPOS 1999;3:117-124.
85. Mandal AK, Gothwal VK, Bagga H, Nutheti R, Mansoori T. Outcome of surgery on infants younger than 1 month with congenital glaucoma. Ophthalmology 2003;110:1909-1915.
86. Wells AP, Cordeiro MF, Bunce C, Khaw PT. Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology 2003;110:2192-2197.
87. Susanna R, Oltrogge EW, Carani JE, Nicolela MT. Mitomycin as adjunct chemotherapy with trabeculectomy in congenital and developmental glaucomas. J Glaucoma 1995;4:151-157.
88. Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R. Trabeculectomy with mitomycin-C in the treatment of pediatric glaucoma. Ophthalmology 2000;107:422-429.
89. Agarwal HC, Sood NN, Sihota R, Sanga L, Honavar SG. Mitomycin-C in congenital glaucoma. Ophthalmic Surg Lasers 1997;28:979-985.
90. Tannenbaum DP, Hoffman D, Greaney MJ, Caprioli J. Outcomes of bleb excision and conjunctival advancement for leaking or hypotonous eyes after glaucoma filtering surgery. Br J Ophthalmol 2004;88:99-103.
91. Hill R, Heur D, Baerveldt G, Minckler D, Martone J. Molteno implantation for glaucoma in young patients. Ophthalmology 1991;98:1042-1046.
92. Nesher R, Sherwood M, Kass M, Hines J, Kolker A. Molteno implants in children. J Glaucoma 1992;1:228-232.
93. Beck AD, Freedman S, Kammer J, Jin J. Aqueous shunt devices compared with trabeculectomy with Mitomycin-c for children in the first two years of life. Am J Ophthalmol 2003;136:994-1000.
94. Melamed S. Aqueous drainage implants. In: Thomas JV, ed. Glaucoma Surgery. St. Louis: Mosby-Yearbook; 1992:83-85.
95. Coleman A, Smyth R, Wilson R, Tam M. Initial clinical experience with the Ahmed Glaucoma Valve implant in pediatric patients. Arch Ophthalmol 1997;115:186-191.
96. Englert J, Freedman S, Cox T. The Ahmed valve in refractory pediatric glaucoma. Am J Ophthalmol 1999;127:34-42.
97. Morod Y, Donaldson C, Kim Y, Abdolell M, Levin A. The Ahmed drainage implant in the treatment of pediatric glaucoma. Am J Ophthalmol 2003;135:821-829.
98. Al-Torbaq AA, Edward DP. Delayed endophthalmitis in a child following an Ahmed glaucoma valve implant. J AAPOS 2002;6:123-125.
99. Al Faran MF, Tomey KF, Mutlaq FA. Cyclocryotherapy in selected cases of congenital glaucoma. Ophthalmic Surg 1990;21:794-798.
100. Wagle NS, Freedman SF, Buckley EG, Davis JS, Biglan AW. Long-term outcome of cyclocryotherapy for refractory pediatric glaucoma. Ophthalmology 1998;105:1921-1927.
101. Kirwan JF, Shah P, Khaw PT. Diode laser cyclophotocoagulation: role in the management of refractory pediatric glaucomas. Ophthalmology 2002;109:316-323.
102. Plager DA, Neely DE. Intermediate-term results of endoscopic diode laser cyclophotocoagulation for pediatric glaucoma. J AAPOS 1999;3:131-137.
103. Autrata R, Rehurek J. Long-term results of transscleral cyclophotocoagulation in refractory pediatric glaucoma patients. Ophthalmologica 2003;217:393-400.
104. Gonzalez P, Caballero M, Liton PB, Stamer WD, Epstein DL. Expression analysis of the matrix GLA protein and VE-cadherin gene promoters in the outflow pathways. Invest Ophthalmol Vis Sci 2004;45:1389-1396.
105. Libby RT, Smith RS, Savinova OV, et al. Modification of ocular defects in mouse developmental glaucoma models by tyrosinase. Science 2003;299:1578-1581.
106. Vincent AL, Billingsley G, Buys Y, et al. Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene. Am J Hum Genet 2002;70:448-460.